Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew H. Lichtman, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Andrew Lichtman and Tanya Mayadas.
Connection Strength

1.118
  1. Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens. Med (N Y). 2021 Sep 10; 2(9):1050-1071.e7.
    View in: PubMed
    Score: 0.247
  2. Fc?R engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity. Nat Commun. 2021 08 09; 12(1):4791.
    View in: PubMed
    Score: 0.246
  3. Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens. bioRxiv. 2021 May 04.
    View in: PubMed
    Score: 0.242
  4. AKAP9 regulates activation-induced retention of T lymphocytes at sites of inflammation. Nat Commun. 2015 Dec 18; 6:10182.
    View in: PubMed
    Score: 0.167
  5. Human lupus serum induces neutrophil-mediated organ damage in mice that is enabled by Mac-1 deficiency. J Immunol. 2012 Oct 01; 189(7):3714-23.
    View in: PubMed
    Score: 0.133
  6. Defects in CD4+ T cell LFA-1 integrin-dependent adhesion and proliferation protect Cd47-/- mice from EAE. J Leukoc Biol. 2017 02; 101(2):493-505.
    View in: PubMed
    Score: 0.045
  7. Dendritic Cells in Kidney Transplant Biopsy Samples Are Associated with T Cell Infiltration and Poor Allograft Survival. J Am Soc Nephrol. 2015 Dec; 26(12):3102-13.
    View in: PubMed
    Score: 0.040
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.